The US FDA Reverses Decision And Allows Oxitriptan Compounding For Now

 
• By Joanne S. Eglovitch
  
Side view of titration in a compounding pharmacy
Appeal gained reprieve for oxitriptan
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Manufacturing

More from Compliance